Takeda Pharmaceutical Co Ltd (TSE:4502)
円 5,540 +115 (+2.12%) Market Cap: 8.85 Tn Enterprise Value: 13.26 Tn PE Ratio: 0 PB Ratio: 1.16 GF Score: 66/100

Q2 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Oct 27, 2022 / 09:30AM GMT
Release Date Price: 円3807 (-0.47%)

Oct 27, 2022 / 09:30AM GMT
Presentation
Oct 27, 2022 / 09:30AM GMT

=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Director of IR
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Giles Platford
Takeda Pharmaceutical Company Limited - President of the Plasma-Derived Therapies Business Unit
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Masato Iwasaki
* Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division
* Teresa Bitetti
Takeda Pharmaceutical Company Limited - President of the Global Oncology Business Unit

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot